-
1.发明授权Container and method for facilitating disposal of unused pharmaceutical product 有权容器和方法，以便于处理未使用的药品公开(公告)号：US09005098B2
公开(公告)日：2015-04-14
申请号：US13925680
申请日：2013-06-24
申请人： Mallinckrodt LLC
发明人： Robert J. Ziemba
摘要： Containers and methods for disposing unused pharmaceutical product are disclosed. Each container (100, 200, 300) may include a container body (104, 204, 304) with an internal chamber (116, 216, 316) for storing pharmaceutical product, along with a cover (124, 224, 324) for selectively limiting access to the chamber (116, 216, 316). An encapsulation component (128, 228, 328) may be selectively disposable within the chamber (116, 216, 316), and may be operable to encapsulate the pharmaceutical product within the container (100, 200, 300). For instance, the encapsulation component (128, 228, 328) may melt and/or flow into contact with the pharmaceutical product and thereafter solidify to encapsulate the pharmaceutical product. The encapsulation component (128, 228, 328) may melt and thereafter solidify between the cover (124, 224, 324) and shell (104, 204, 304) to limit removal of the cover (124, 224, 324) from the shell (104, 204, 304).
摘要翻译： 公开了处置未使用的药品的容器和方法。 每个容器（100,200,300）可以包括具有用于储存药物产品的内部腔室（116,216,316）的容器体（104,204,304），以及用于选择性地 限制对腔室（116,216,316）的通路。 封装组件（128,228,328）可以在腔室（116,216,316）内选择性地一次性使用，并且可以可操作地将药物产品包封在容器（100,200,300）内。 例如，包封组分（128,228,328）可以熔化和/或流动与药物产物接触，然后固化以包封药物产品。 封装组件（128,228,328）可以熔化，然后在盖（124,224,324）和壳体（104,204,304）之间固化，以限制从壳体（124,224,324）除去壳体 （104,204,304）。
-
公开(公告)号：US20130087475A1
公开(公告)日：2013-04-11
申请号：US13691766
申请日：2012-12-01
申请人： MALLINCKRODT LLC
IPC分类号： A61J1/03
CPC分类号： A61J1/035 , B65D53/08 , B65D75/367 , B65D75/38 , B65D83/0463 , B65D2575/365
摘要： A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).
-
公开(公告)号：US09579252B2
公开(公告)日：2017-02-28
申请号：US14716269
申请日：2015-05-19
申请人： Mallinckrodt LLC
CPC分类号： A61J1/035 , B65D53/08 , B65D75/367 , B65D75/38 , B65D83/0463 , B65D2575/365
摘要： A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).
摘要翻译： 药物产品供应品以容器，药物产品接收器，药物产品，粘合剂和至少一个释放衬垫的形式被公开。 药品接收器包括用于药物产品的多个容器。 容器最初设置在第一配置中，其中所有药物接收器容器都可以接近。 此后，该容器是一次性的，其中没有用于任何药物产品接收器容器的覆盖物可通过容器所包含的任何可开放的通路进入。 可以移动一个或多个隔离衬片以露出用于将容器设置和保持在其第二构造中的粘合剂。 所述容器的所述第二配置有助于处置药物产品供应（例如，现在处于应当减少获得仍然包围在药物产品接收器内的任何剩余药物的潜力的形式）。
-
公开(公告)号：US09414989B2
公开(公告)日：2016-08-16
申请号：US14488048
申请日：2014-09-16
申请人： Mallinckrodt LLC
CPC分类号： A61J1/1437 , A61J1/03 , A61J1/14 , B65D45/00 , B65D55/12 , B65D2255/20 , E05B73/0023
摘要： Various embodiments of pharmaceutical product containers are disclosed. Each pharmaceutical product container includes a cap, a container body, and a locking mechanism. The locking mechanism is disposable from a locked state to an unlocked state at least when the cap is in a closed position relative to the container body (e.g., to define an enclosed space for pharmaceutical product). Once in the locked state and with the cap being in a closed position, the locking mechanism is unable to return to its unlocked state. Pharmaceutical product enclosed within the container with the locking mechanism being in its locked state may then be disposed of in any appropriate manner (e.g., discarded in the trash).
摘要翻译： 公开了药品容器的各种实施方案。 每个药品容器包括帽，容器主体和锁定机构。 至少当盖子相对于容器主体处于关闭位置（例如为了制定用于制药产品的封闭空间）时，锁定机构可以从锁定状态一次性到解锁状态。 一旦处于锁定状态并且盖处于关闭位置，锁定机构就不能返回其解锁状态。 封闭在具有锁定机构处于其锁定状态的容器内的药品可以以任何适当的方式（例如，丢弃在垃圾中）进行处置。
-
公开(公告)号：US20150001102A1
公开(公告)日：2015-01-01
申请号：US14488048
申请日：2014-09-16
申请人： Mallinckrodt LLC
IPC分类号： A61J1/14
CPC分类号： A61J1/1437 , A61J1/03 , A61J1/14 , B65D45/00 , B65D55/12 , B65D2255/20 , E05B73/0023
摘要： Various embodiments of pharmaceutical product containers are disclosed. Each pharmaceutical product container includes a cap, a container body, and a locking mechanism. The locking mechanism is disposable from a locked state to an unlocked state at least when the cap is in a closed position relative to the container body (e.g., to define an enclosed space for pharmaceutical product). Once in the locked state and with the cap being in a closed position, the locking mechanism is unable to return to its unlocked state. Pharmaceutical product enclosed within the container with the locking mechanism being in its locked state may then be disposed of in any appropriate manner (e.g., discarded in the trash).
摘要翻译： 公开了药品容器的各种实施方案。 每个药品容器包括帽，容器主体和锁定机构。 至少当盖子相对于容器主体处于关闭位置（例如为了制定用于制药产品的封闭空间）时，锁定机构可以从锁定状态一次性到解锁状态。 一旦处于锁定状态并且盖处于关闭位置，锁定机构就不能返回其解锁状态。 封闭在具有锁定机构处于其锁定状态的容器内的药品可以以任何适当的方式（例如，丢弃在垃圾中）进行处置。
-
公开(公告)号：US09168335B2
公开(公告)日：2015-10-27
申请号：US14186914
申请日：2014-02-21
申请人： MALLINCKRODT LLC
发明人： Charles S. Neer , Robert J. Ziemba , David M. Brooks , James R. Small , Jonathan D. Gibbs , John Kevin Bruce , Gary S. Wagner
CPC分类号： A61M5/007 , A61B6/548 , A61M5/14546 , A61M5/14566 , A61M5/16827 , A61M5/1785 , A61M2205/3306 , A61M2205/3317 , A61M2205/3389 , A61M2205/502 , A61M2205/52 , A61M2205/587 , A61M2205/6054 , A61M2205/6063
摘要： A contrast media injection system includes detects the absolute position of the syringe ram using a non-contact sensor. A series of magnets and Hall-Effect sensors may be used or an opto-reflective system. Illuminated knobs that are connected to the drive mechanism for the syringe ram rotate with the drive and provide visual feedback on operation through the illumination. Analog Hall-Effect sensors are used to determine the presence or absence of magnets that identify the type of faceplate being used. The faceplates include control electronics, connected to the powerhead through connectors, which may be interchangeably used by the two faceplates. The faceplate electronics include detectors for automatically detecting the capacity of pre-filled syringes. Additional features include using historical data to provide optimum pressure limit values during an injection protocol, a removable memory device for storing and transferring information such as injection protocols and injector statistics, and password protection of such protocols.
-
公开(公告)号：US20140083900A1
公开(公告)日：2014-03-27
申请号：US14092559
申请日：2013-11-27
申请人： Mallinckrodt LLC
CPC分类号： A61J1/035 , B65D53/08 , B65D75/367 , B65D75/38 , B65D83/0463 , B65D2575/365
摘要： A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).
摘要翻译： 药物产品供应品以容器，药物产品接收器，药物产品，粘合剂和至少一个释放衬垫的形式被公开。 药品接收器包括用于药物产品的多个容器。 容器最初设置在第一配置中，其中所有药物接收器容器都可以接近。 此后，该容器是一次性的，其中没有用于任何药物产品接收器容器的覆盖物可通过容器所包含的任何可开放的通路进入。 可以移动一个或多个隔离衬片以露出用于将容器设置和保持在其第二构造中的粘合剂。 所述容器的所述第二配置有助于处置药物产品供应（例如，现在处于应当减少获得仍然包围在药物产品接收器内的任何剩余药物的潜力的形式）。
-
8.发明申请公开(公告)号：US20130283734A1
公开(公告)日：2013-10-31
申请号：US13925680
申请日：2013-06-24
申请人： Mallinckrodt LLC
发明人： Robert J. Ziemba
IPC分类号： B65B3/04
摘要： Containers and methods for disposing unused pharmaceutical product are disclosed. Each container (100, 200, 300) may include a container body (104, 204, 304) with an internal chamber (116, 216, 316) for storing pharmaceutical product, along with a cover (124, 224, 324) for selectively limiting access to the chamber (116, 216, 316). An encapsulation component (128, 228, 328) may be selectively disposable within the chamber (116, 216, 316), and may be operable to encapsulate the pharmaceutical product within the container (100, 200, 300). For instance, the encapsulation component (128, 228, 328) may melt and/or flow into contact with the pharmaceutical product and thereafter solidify to encapsulate the pharmaceutical product. The encapsulation component (128, 228, 328) may melt and thereafter solidify between the cover (124, 224, 324) and shell (104, 204, 304) to limit removal of the cover (124, 224, 324) from the shell (104, 204, 304).
摘要翻译： 公开了处置未使用的药品的容器和方法。 每个容器（100,200,300）可以包括具有用于储存药物产品的内部腔室（116,216,316）的容器体（104,204,304），以及用于选择性地 限制对腔室（116,216,316）的通路。 封装组件（128,228,328）可以在腔室（116,216,316）内选择性地一次性使用，并且可以可操作地将药物产品包封在容器（100,200,300）内。 例如，包封组分（128,228,328）可以熔化和/或流动与药物产物接触，然后固化以包封药物产品。 封装组件（128,228,328）可以熔化，然后在盖（124,224,324）和壳体（104,204,304）之间固化，以限制从壳体（124,224,324）除去壳体 （104,204,304）。
-
公开(公告)号：US09120607B2
公开(公告)日：2015-09-01
申请号：US14092559
申请日：2013-11-27
申请人： Mallinckrodt LLC
CPC分类号： A61J1/035 , B65D53/08 , B65D75/367 , B65D75/38 , B65D83/0463 , B65D2575/365
摘要： A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).
摘要翻译： 药物产品供应品以容器，药物产品接收器，药物产品，粘合剂和至少一个释放衬垫的形式被公开。 药品接收器包括用于药物产品的多个容器。 容器最初设置在第一配置中，其中所有药物接收器容器都可以接近。 此后，该容器是一次性的，其中没有用于任何药物产品接收器容器的覆盖物可通过容器所包含的任何可开放的通路进入。 可以移动一个或多个隔离衬片以露出用于将容器设置和保持在其第二构造中的粘合剂。 所述容器的所述第二配置有助于处置药物产品供应（例如，现在处于应当减少获得仍然包围在药物产品接收器内的任何剩余药物的潜力的形式）。
-
公开(公告)号：US20150127376A1
公开(公告)日：2015-05-07
申请号：US14398392
申请日：2013-05-07
申请人： Mallinckrodt LLC
发明人： Vernon D. Ortenzi , John Edward Powers , Robert J. Ziemba , Rhonda J. Soest , Pamela J. Pollard
CPC分类号： G16H40/63 , A61M5/007 , A61M5/14546 , A61M31/005 , A61M2005/14553 , A61M2205/33 , A61M2205/35 , A61M2205/52 , G06F19/321 , G16H10/60 , G16H50/30 , H04L67/12
摘要： Contrast administration data that relates to operation of a contrast media injector system (602) may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) by an injection data management module (660) for use by a medical system (600). Data on contrast media prescribed for an imaging operation using an imaging system (690), contrast media data for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system (602) for this imaging operation may be stored in a data structure (780) on the injection data management module (660). Patient renal function data may be used to control the dispensing of contrast media from a contrast media/storage/dispensing unit (500), to control the operation of the contrast media injector system (602), or both, and may be stored in the data structure (780) as well.
摘要翻译： 与造影剂注射器系统（602）的操作相关的对比度管理数据可以从至少一种格式（例如，CAN兼容格式）转换为至少一种其他格式（例如，符合HL-7的格式） 通过由医疗系统（600）使用的注射数据管理模块（660）。 用于使用成像系统（690）的成像操作规定的造影剂的数据，用于该成像操作的造影剂数据以及由该成像操作实际施用/注射的造影介质注射器系统（602）的造影剂的数据可以 被存储在喷射数据管理模块（660）上的数据结构（780）中。 可以使用患者肾功能数据来控制来自造影剂/存储/分配单元（500）的造影剂的分配，以控制造影剂注射器系统（602）或两者的操作，并且可以存储在 数据结构（780）。
-
-
-
-
-
-
-
-
-
搜索结果
15 条记录 (耗时 0.016 秒)
